www.hivandhepatitis.com

  • RSS

    Syndicate Feeds

    feed-image Feed Entries
  • Twitter
  • Youtube
  • Facebook
  • Contact Us
  • Home
    • About Us
      • Our Team
      • The Fine Print
      • Overview
    • Get in touch
      • Contact Us
      • Find Us on Facebook
    • Content
      • Past Conferences
      • Conference Coverage
      • Library of CME Programs
  • HIV/AIDS
    • HIV/AIDS Topics
      • HIV Prevention
      • HIV Disease Progression
      • HIV Populations
      • HIV Treatment
      • HIV Testing & Diagnosis
      • HIV-Related Conditions
  • Hepatitis B
    • Hepatitis B Topics
      • HBV Treatment
      • HBV Disease Progression
      • HBV Populations
      • HBV Prevention
      • HBV Testing & Diagnosis
  • Hepatitis C
  • HIV/Hepatitis Coinfection
    • HIV/HBV Coinfection
    • HIV/HCV Coinfection
  • Other Health News
    • Other Health News Topics
      • Influenza
      • Tuberculosis
      • Human Papillomavirus (HPV)
      • Other STDs
      • XMRV, MLV & Other Retroviruses
  • Skip to content
Back HCV Disease Progression

AASLD 2009: Study Looks at Factors Affecting Survival of HIV/HCV Coinfected Liver Transplant Recipients

Details
Category: Liver Transplant - HCV
Published on Friday, 13 November 2009 12:46
Written by Liz Highleyman
  • Print
  • Email

While HIV/HCV coinfected patients can have good outcomes after liver transplantation, acute organ rejection remains a risk factor and survival does not match that of HIV negative people with hepatitis C virus (HCV) alone, according to a study presented at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2009) this month in Boston.

Read more:

More Articles...

  1. Rapid Liver Fibrosis Progression and Successful Treatment of Acute Infection Suggest Benefits of Routine HCV Screening for HIV Positive Men
  2. Metabolic Syndrome Is Associated with Increased Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients
  3. EASL 2009: Early Treatment of Acute Hepatitis C with Pegylated Interferon Monotherapy Produces Better Results than Delayed Combination Therapy
  4. Long-term Maintenance Interferon Does Not Prevent Hepatocellular Carcinoma among Chronic Hepatitis C Patients in HALT-C Study
  5. Older Donor Liver Grafts May Be Suitable for Chronic Hepatitis C Patients Requiring Transplantation

Subcategories

  • Acute Hepatitis C
  • Fibrosis & Cirrhosis
  • Liver Cancer/HCC
  • Decompensation & ESLD
  • Liver Transplant - HCV

Page 88 of 99

  • Start
  • Prev
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • Next
  • End

Hepatitis C Topics

  • HCV Disease Progression
    • Acute Hepatitis C
    • Fibrosis/Cirrhosis
    • Liver Cancer/HCC
    • Transplant/Artificial Liver
  • HCV-Related Conditions
  • HCV Basic Science
  • HCV Epidemiology
  • HCV Populations
  • HCV Policy & Advocacy
  • HCV Treatment
    • Approved HCV Drugs
    • Experimental HCV Drugs
    • Treatment Guidelines
    • Response Predictors
  • HCV Prevention
    • HCV Sexual Transmission
  • HCV Testing & Diagnosis
  • Side Effects - HCV

CONFERENCE COVERAGE

alt The Liver Meeting (AASLD 2017) 
October 20-24, 2017, Washington, DC
alt

6th European AIDS Conference (EACS 2017)
October 20-27, 2017, Milan

alt 9th IAS Conference on HIV Science (IAS 2017)
July 23-26, 2017, Paris
alt 2017 Harm Reduction International Conference 
May 14-17, 2017, Montreal
alt 2017 Pediatric Academic Societies Meeting
May 6-9, 2017, San Francisco
alt 2017 EASL International Liver Congress
April 19-23, 2017, Amsterdam
alt 2017 Conference on Retroviruses and Opportunistic Infections (CROI 2017) 
February 13-16, 2017, Seattle
alt The Liver Meeting (AASLD 2016) 
November 11-15, 2016, Boston
alt IDWeek 2016
October 26-30, 2016, New Orleans
alt HIV Drug Therapy 2016 
October 23-26, 2016, Glasgow
alt HIV Research for Prevention (HIVR4P 2016)
October 17-21, 2016, Chicago
alt 5th International Symposium on Hepatitis Care in Substance Users (INHSU 2016)
Sept 7-9, 2016, Oslo
alt 21st International AIDS Conference (AIDS 2016) 
July 18-22, 2016, Durban
alt ASM Microbe 2016/ICAAC 2016
June 16-20, 2016, Boston
alt 2016 EASL International Liver Congress
April 13-17, 2016, Barcelona
alt 2016 Conference on Retroviruses and Opportunistic Infections (CROI 2016) 
February 22-25, 2016, Boston
alt 2015 National HIV Prevention Conference (NHPC 2015) 
December 6-9, 2015, Atlanta
alt 46th Union World Conference on Lung Health 
December 2-6, 2015, Cape Town
alt The Liver Meeting (AASLD 2015) 
November 13-17, 2015, San Francisco
alt 15th European AIDS Conference (EACS 2015) 
October 21-24, 2015, Barcelona
alt 24th International Harm Reduction Conference (IHRC 2015)
October 18-21, 2015, Kuala Lumpur
alt IDWeek 2015
October 7-11, 2015, San Diego
alt 4th International Symposium on Hepatitis Care in Substance Users (INHSU 2015)
October 7-9, 2015, Sydney
alt 55th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2015)
September 17-21, 2015, San Diego
alt 8th International AIDS Society Conference on HIV Pathogenesis, Treatment & Prevention (IAS 2015) 
July 19-22, 2015, Vancouver
alt Digestive Disease Week 2015
May 16-19, 2015, Washington, DC
alt 50th International Liver Congress (EASL 2015) 
April 22-26, 2015, Vienna
alt

21st Annual Meeting of the British HIV Association (BHIVA) 
April 21-24, 2015, Brighton

alt 2015 Conference on Retroviruses and Opportunistic Infections (CROI 2015) 
February 23-26, 2015, Seattle

Previous Conferences...

  • Home
  • About
  • Contact Us
Copyright © 2025 www.hivandhepatitis.com. All Rights Reserved. Designed by JoomlArt.com. Joomla! is Free Software released under the GNU General Public License.

Bread and Roses Web DesignWeb Design and Development by Bread and Roses Web Design